Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

NCT04692103 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Estrogen Receptor Positive
Primary or Recurrent Breast Carcinoma
Stage IV Breast Cancer AJCC v6 and v7

Interventions

DRUG: F-18 16 Alpha-Fluoroestradiol
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
DRUG: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Washington